Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Germany Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20064
20072
20082
20093
20104
20114
20128
20133
20141
20155
20174
20183
20191
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GBG Forschungs GmbH4
GlaxoSmithKline3
Hoffmann-La Roche3
Pfizer3
European Organisation for Research and Treatment of Cancer - EORTC2
AEterna Zentaris1
AIO-Studien-gGmbH1
AVEO Pharmaceuticals, Inc.1
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms54
Neoplasm Metastasis6
Brain Neoplasms3
Lung Neoplasms3
Colorectal Neoplasms2
Ovarian Neoplasms2
Recurrence2
Carcinoma, Adenoid Cystic1
Carcinoma, Hepatocellular1
Glioblastoma1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.